13-10-2026 05:58
via
smh.com.au
NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle
NeuroScientific Biopharmaceuticals has landed key US backing for its Phase 2 stem cell Crohn’s trial, green-lighting a planned year-end start subject to final preparations.
Read more »
Analyst news
More than 300 scientists say AI oversight needed after 'preventable' hacks
Germany's Nuremberg Airport reopens after aviation emergency
Germany's Nuremberg Airport closes due to aviation emergency
Germany scrambles jets after airline radio glitch sends false hijack alert
Breaking: Germany's Nuremberg Airport closes due to aviation emergency
Red tape snarl costs business $160b
PM personally brokered ATO credit card pause
Defence player in Federal Court peace talks
Aussie shares pare early losses, mining and tech drop
Big Egg cartel: Major Australian suppliers accused of whipping up higher prices
At Close of Business podcast October 13 2026
Stirling seeks input for Scarborough revamp
WA leads nation in visitor recovery
ASX ends flat after slow session on Wall Street; Tech stocks slump, banks jump
Desktop versie